Compression for the management of venous leg ulcers: which material do we have?
Hugo Partsch
https://pubmed.ncbi.nlm.nih.gov/24843100Actively Recruiting
Led by Pirogov Russian National Research Medical University · Updated on 2024-12-27
90
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating the effects of pelvic varicose veins (PVV) and pelvic congestion syndrome (PCS) on venous outflow from the lower limbs in women with chronic venous disease (CVD). This observational study aims to understand how symptomatic and asymptomatic PVV impact the clinical course of CVD and the potential role of compression therapy. The study addresses the relationship between pelvic and lower limb varicose veins, including their frequency, symptoms, and hemodynamic disturbances, to improve treatment strategies and develop targeted compression products. The study includes three groups: 40 women with symptomatic PVV without signs of CVD, 40 women with asymptomatic PVV showing signs of CVD, and 10 women with varicose veins of the lower limb without PVV or PCS. Participants undergo diagnostic tests including radionuclide venography and single-photon emission computed tomography (SPECT) to assess venous outflow and pelvic venous congestion. The study duration is from May 2023 to January 2024, focusing on measuring isotope transport time and the coefficient of pelvic venous congestion. Participants will be monitored through imaging studies and clinical assessments at baseline and after 10 days. Researchers will evaluate venous blood flow, pelvic vein reflux, and symptoms related to pelvic congestion. The main outcomes include the average transport time of an injected isotope and a quantitative pelvic venous congestion coefficient. These results will help clarify the role of compression therapy and venous outflow disorders in women with PVV and CVD, aiming to improve conservative treatment options and clinical management.
CONDITIONS
Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 day
Participants undergo radionuclide venography and single-photon emission computed tomography (SPECT) to assess venous outflow from the lower limbs and pelvic veins.
1 visit (in-person)
Duration - 10 days
Participants are observed to evaluate venous outflow characteristics and clinical manifestations over time without receiving active treatment.
1 follow-up visit
Total: 1 location
1
Ananstsia Grishenkova
Moskva, Russia, 119049
Actively Recruiting
S
Sergey G Gavrilov, MD, PhD
A
Anatoly V Karalkin, MD, PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Hugo Partsch
https://pubmed.ncbi.nlm.nih.gov/24843100F Vin, J P Benigni, International Union of Phlebology...
https://pubmed.ncbi.nlm.nih.gov/15767979A Nicolaides, S Kakkos, B Eklof...
https://pubmed.ncbi.nlm.nih.gov/24780922S G Gavrilov, A V Karalkin, O O Turischeva
https://pubmed.ncbi.nlm.nih.gov/28639874Neslihan Zehra Gültaşli, Aydin Kurt, Ali Ipek...
https://pubmed.ncbi.nlm.nih.gov/16538582Alice M Whiteley, Daniel C Taylor, Scott J Dos Santos...
https://pubmed.ncbi.nlm.nih.gov/26993547A Bora, S Avcu, H Arslan...
https://pubmed.ncbi.nlm.nih.gov/23019985